INHIBITION OF HEPATIC TRIGLYCERIDE FORMATION BY CLOFIBRATE

被引：108

作者：

ADAMS, LL

WEBB, WW

FALLON, HJ

机构：

来源：

关键词：

D O I：

10.1172/JCI106732

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：2339 / &

共 40 条

[1]

ADAMS LL, 1970, CLIN RES, V18, P50

[2]

AMENTA JS, 1964, J LIPID RES, V5, P270

[3]

AVOY DR, 1965, J LIPID RES, V6, P369

[4] STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE) [J].

AZARNOFF, DL ;

TUCKER, DR ;

BARR, GA .

METABOLISM, 1965, 14 (09) :959-&

[5]

BAKER N, 1967, J LIPID RES, V8, P646

[6]

BAKER N, 1964, J LIPID RES, V5, P188

BARRETT, AM .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1966, 26 (02) :363-&

[8]

BEST MM, 1964, J LAB CLIN MED, V64, P634

[9]

Bierman E L, 1970, Trans Assoc Am Physicians, V83, P211

CENEDELLA, RJ ;

JARRELL, JJ ;

SAXE, LH .

JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1968, 8 (06) :903-+